Open Market Consultation of PROCURE4HEALTH for the future Pre-Commercial Procurement of R&D services and/or Public Procurement of Innovative Solutions on the health sector

This Prior Information Notice announces an OMC conducted by the PROCURE4HEALTH project and provides information about a potential future Pre-Commercial Procurement (PCP) of R&D services and/or Public Procurement of Innovative Solutions (PPI) on the health sector. PROCURE4HEALTH has received funding from the Horizon Europe Framework Programme (HORIZON) under grant agreement n. 101057209. However, the European Union will not participate as a contracting authority in the procurement. PROCURE4HEALTH aims to challenge the market to develop innovative solutions to tackle 4 common challenges related to: (1) On-site treatment of hospital wastewater, (2) Reusable personal protection against pathogens, (3) Digitalisation of integrated care, and (4) Predictive medicine. The OMC documents will be published in due time on the PROCURE4HEALTH website: www.procure4health.eu

The PIN announces the Open Market Consultation of a potential future Pre-Commercial Procurement (PCP) of R&D services and/or Public Procurement of Innovative Solutions (PPI). PCP is an approach that allows public procurers to buy R&D from several competing suppliers in parallel, to compare alternative solution approaches, and to identify the best value-for-money solutions that the market can deliver to address their needs. It is split into three phases: solution design, prototype implementation, and validation and demonstration of the solutions. In PCP, there is a risk-benefit sharing under market conditions between the public procurer and the suppliers, and a clear separation between the PCP and the deployment of commercial volumes of end-products. The PCP procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them.

PPI happens when the public sector uses its purchasing power to act as early adopter of innovative solutions which are not yet available on large scale commercial basis. It is subjected to the rules and procedures established in the EU public procurement directives.

The law applicable to the procurement will be the law of the lead procurer, which is Spanish law.